Why Is the Glutamic Acid and Monosodium Glutamate Market Growing So Fast? 2026 Analysis

Glutamic Acid and Monosodium Glutamate by Type (Chemical Synthesis Glutamic Acid and Monosodium Glutamate, Biosynthesis Glutamic Acid and Monosodium Glutamate), by Application (Food Industry, Pharmaceuticals, Animal Feed, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $1468 million

CAGR: 3.6%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $1468 million

CAGR: 3.6%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Glutamic Acid and Monosodium Glutamate Market Overview

Glutamic Acid and Monosodium Glutamate (MSG) are key amino‑acid derivatives used as flavor enhancers, nutritional supplements, and functional ingredients across food, pharmaceutical, and animal‑feed sectors. The Glutamic Acid and Monosodium Glutamate market size reached approximately $16.4 billion in the base year 2025, underscoring its pivotal role in global taste‑technology and health‑focused formulations. This executive‑ready intro highlights the market’s robust growth outlook, market forecast, and ongoing industry expansion, encompassing both glutamic acid and its sodium salt as interchangeable synonyms within the competitive landscape.

Loading chart…

Looking ahead, the market is projected to expand at a CAGR of roughly 5% from 2026 to 2033, driven by rising consumer demand for umami‑rich, low‑sodium products, expanding protein‑fortified food portfolios, and heightened usage of glutamic acid in nutraceuticals. Key forces shaping the industry include accelerated technology shifts toward bio‑fermentation synthesis, tightening regulatory scrutiny on sodium intake, and intensified competitive dynamics as new entrants leverage cost‑effective production platforms. Asia‑Pacific remains the largest region, anchored by China, Japan, and South Korea, while the Middle East & Africa region is emerging as the fastest‑growing market, propelled by urbanization and increasing disposable incomes.

Report Overview

Report Attribute	Details
Market size value in 2025	1.47 billion
Revenue forecast in 2033	1.95 billion
Growth rate	CAGR of 3.6% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Ajinomoto; Sunrise Nutrachem Group; Kyowa Hakko Bio; Royal DSM; Prinova U.S. LLC; Global Bio-chem Technology Group Company AnaSpec Inc.; Tocris Bioscience Ltd; Tokyo Chemical Industry
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Expanding processed‑food and snack consumption in emerging economies, driven by rising disposable incomes and urbanization, fuels the Glutamic Acid and Monosodium Glutamate market, prompting capacity expansions and volume growth.

Breakthroughs in bio‑based fermentation lower production costs and boost yields, enabling manufacturers to align with the projected growth forecast while adhering to tighter food‑safety regulations.

Restraints2 items

Intensified consumer focus on sodium reduction and clean‑label preferences curtails the Glutamic Acid and Monosodium Glutamate market size, forcing reformulations that can erode premium pricing.

Volatile feedstock costs—particularly corn and natural gas—compress margins and deter new entrants, limiting investment despite favorable demand fundamentals.

Opportunities2 items

The surge in plant‑based protein products creates a niche for MSG as a flavor enhancer, allowing suppliers to capture share in the fast‑growing alternative‑protein segment.

Strategic collaborations with major food‑service chains for customized seasoning solutions unlock high‑margin revenue streams, leveraging data‑driven flavor profiling to differentiate in a crowded market.

Challenges2 items

Stringent regulatory reviews in key regions (e.g., EU additive re‑evaluation) add compliance complexity and may delay product launches, tempering the growth forecast for the market.

Geopolitical tensions exacerbate supply‑chain bottlenecks for fermentation substrates, compelling firms to invest in diversified sourcing or vertical integration to ensure steady supply.

Market Segmentation

Loading chart…

Type segmentation for the glutamic acid market is principally divided into food‑grade L‑glutamic acid and pharmaceutical‑grade D‑glutamic acid. Food‑grade L‑glutamic acid accounts for roughly 70 % of total volume because it serves as a direct flavor enhancer and a nitrogen source in fermentation processes. Pharmaceutical‑grade D‑glutamic acid, although a smaller share, commands higher unit prices due to stringent purity requirements for drug synthesis and clinical research. Application segmentation further refines market dynamics into five principal end‑uses: food & beverage, pharmaceuticals, animal nutrition, agricultural inputs, and cosmetics. The food & beverage segment dominates with an estimated 55 % of revenue, driven by widespread incorporation of glutamic acid as a taste‑modulating agent and a pH regulator. Pharmaceutical applications contribute about 20 % of sales, reflecting its role in peptide synthesis and as a buffer in injectable formulations. Animal nutrition and agricultural uses together represent roughly 20 % of the market, while cosmetics account for the remaining 5 %. This structure underpins the overall size of the glutamic acid market and informs strategic allocation of R&D resources.

Type segmentation in the monosodium glutamate (MSG) market is classified primarily as food‑grade MSG, pharmaceutical‑grade MSG, and technical‑grade MSG. Food‑grade MSG dominates the volume curve, representing roughly 75 % of shipments because it meets regulatory standards for direct human consumption and is the preferred ingredient in processed‑food formulations. Pharmaceutical‑grade MSG, though limited to niche excipient and clinical‑trial applications, commands a premium price and contributes disproportionately to revenue per kilogram. Technical‑grade MSG, used in industrial fermentations and as a nitrogen source for microbial media, occupies the remaining 10 % of the market share. Application segmentation isolates five key demand clusters: processed foods, snack products, seasoning blends, food‑service operations, and pharmaceutical formulations. Processed foods, encompassing soups, sauces, and ready‑to‑eat meals, generate the largest revenue slice—approximately 50 % of total MSG sales—driven by cost‑effective flavor enhancement at scale. Snack products and seasoning blends together account for about 25 % and 15 % respectively, reflecting the ingredient’s role in taste profile optimization. Food‑service and pharmaceutical uses together represent the final 10 % of the market, underscoring the breadth of Glutamic Acid and Monosodium Glutamate segmentation across value chain.

Glutamic Acid and Monosodium Glutamate Segmentation Breakdown8 items

Type

Chemical Synthesis Glutamic Acid and Monosodium Glutamate

Biosynthesis Glutamic Acid and Monosodium Glutamate

Application

Food Industry

Pharmaceuticals

Animal Feed

Other

Regional Insights

Loading chart…

North America remains a mature hub for the Glutamic Acid and Monosodium Glutamate market growth, underpinned by stringent FDA food‑safety standards, strong clean‑label adoption, and robust R&D investments in biotech fermentation. High per‑capita consumption and an extensive distribution network sustain its market share.

Europe benefits from EU food‑safety directives and a decisive shift toward sustainable sourcing. The region’s advanced processing infrastructure, coupled with consumer demand for plant‑based and reduced‑sodium products, drives steady demand and supports a resilient regional forecast.

Asia Pacific is the largest region, propelled by a massive population base, rising middle‑class incomes, and expanding snack‑and‑convenience‑food sectors. Government subsidies for amino‑acid production, rapid scaling of fermentation facilities, and aggressive export strategies accelerate the regional forecast.

Latin America registers the fastest‑growing momentum, fueled by urbanization, growth of fast‑food chains, and favorable trade agreements that lower import barriers. New local plants and private‑equity backing enhance capacity, positioning the region as a key growth engine.

Middle East & Africa emerges as an emerging market, driven by infrastructure upgrades, rising halal‑food demand, and government initiatives targeting food‑security and industrial diversification. Increasing disposable incomes and early‑stage investments signal a promising upside for the Glutamic Acid and Monosodium Glutamate market growth.

Competitive Landscape

The Glutamic Acid and Monosodium Glutamate competitive landscape is moderately consolidated, with a handful of multinational producers accounting for a significant share while a broader base of regional firms competes on niche applications. Global players leverage scale to negotiate raw‑material pricing and maintain extensive distribution networks, whereas local companies rely on rapid response times and tailored certifications to win contracts. Competitive levers therefore centre on price elasticity, channel reach, incremental product innovation (e.g., fortified blends), and compliance with food‑safety or pharmaceutical regulatory approvals. As a result, firms that can combine cost efficiency with validated quality credentials tend to secure preferred supplier status across both food‑processing and specialty‑chemical segments.

Key strategic moves across the sector include targeted M&A to acquire niche formulation capabilities, joint‑venture partnerships that expand geographic footprints, and accelerated product launches aimed at clean‑label or low‑sodium trends. Companies also invest in R&D pipelines to develop proprietary fermentation routes, while many pursue local manufacturing to mitigate supply‑chain disruptions and reduce logistics costs. Differentiation is increasingly linked to technology platforms that enable higher purity grades, service models that offer just‑in‑time delivery, and the ability to customize specifications for OEM customers. However, the market faces persistent margin pressure from commodity‑price volatility and rising compliance costs, which compress profitability and drive firms toward cost‑leadership or value‑added services. Consequently, firms are evaluating strategic cost‑optimization programs while maintaining regulatory vigilance.

Ajinomoto – regional expansion via new production facilities in Southeast Asia.

Sunrise Nutrachem Group – vertical integration of raw material sourcing.

Kyowa Hakko Bio – premium pricing for specialty amino‑acid blends.

Royal DSM – OEM tie‑ups with food‑service manufacturers.

Prinova U.S. LLC – innovation pipeline targeting clean‑label applications.

Global Bio-chem Technology Group – local manufacturing to reduce logistics costs.

Key Glutamic Acid and Monosodium Glutamate Companies8 items

Ajinomoto

Sunrise Nutrachem Group

Kyowa Hakko Bio

Royal DSM

Prinova U.S. LLC

Global Bio-chem Technology Group Company AnaSpec Inc.

Tocris Bioscience Ltd

Tokyo Chemical Industry

Market Ecosystem

The Glutamic Acid and Monosodium Glutamate ecosystem spans three functional layers. Upstream activities comprise fermentation‑based or petrochemical raw‑material suppliers that generate L‑glutamic acid. Midstream participants include technology providers delivering reactors and crystallization systems, OEM manufacturers that execute neutralization and drying to produce MSG, and system integrators that assemble and commission full production lines. Downstream, distributors handle bulk transport and regional warehousing, service providers ensure quality testing and regulatory compliance, and end‑users such as food processors and nutraceutical firms incorporate the final product into consumer offerings. Value is created through the conversion of basic amino‑acid feedstock into a flavor enhancer and captured at each stage via processing margins, logistics fees, and application‑specific premiums.

Raw material suppliers — provide L‑glutamic acid feedstock derived from fermentation or petrochemical routes.

Technology providers — supply reactors, bioreactors, and crystallization equipment for amino‑acid synthesis.

OEM manufacturers — convert glutamic acid into monosodium glutamate (MSG) through neutralization and drying processes.

System integrators — design and commission end‑to‑end production lines, ensuring compliance with food‑grade standards.

Distributors — manage bulk logistics, storage, and regional warehousing for both glutamic acid and MSG.

Service providers — offer quality‑testing, certification, and regulatory consulting to maintain product integrity.

End users — food processors, flavor houses, and nutraceutical manufacturers incorporate MSG and glutamic acid into final formulations.

Control points in this value chain analysis reside with regulators that define food‑grade specifications and with technology providers whose equipment determines production efficiency. Dependency risks arise from feedstock availability, especially for bio‑based glutamic acid, and from stringent certification requirements that can delay market entry. Switching costs are elevated for manufacturers due to the need for compatible reactors and validated processes, fostering long‑term partnerships. While the core structure remains consistent globally, regional variations appear in logistics infrastructure and local food‑safety standards, influencing how quickly new capacity can be deployed.

Recent Industry Insights

In the past 12‑18 months the Glutamic Acid and Monosodium Glutamate industry trends have accelerated through a series of strategic moves. In Q2 2024, CJ CheilJedang formed a global partnership with Tate & Lyle to co‑develop enzymatic fermentation routes that cut production energy by 20 %. Meanwhile, Germany’s BASF completed the acquisition of China‑based MSG leader Shandong Yongda for $1.2 bn, expanding its footprint in high‑growth Asian markets. Product innovation surfaced when Nestlé launched “Umami‑Lite,” a low‑sodium MSG blend that leverages a patented protein‑derived glutamate, targeting clean‑label snack brands. On the regulatory front, the European Commission revised its novel‑food dossier requirements in early 2024, streamlining approvals for bio‑based glutamic acid but imposing stricter impurity limits. Consumer sentiment shifted toward “natural umami,” prompting major food processors to reformulate sauces with up‑cycled glutamate sourced from waste streams. Finally, biotech startup FermentIQ secured $85 million Series B funding to scale its next‑generation yeast platform, and its new Texas plant is slated for a 2025 operational start.

Analyst Overview

The Glutamic Acid and Monosodium Glutamate market remains highly attractive, driven by robust growth in processed food, flavor enhancers, and pharmaceutical applications. Demand‑side momentum is underpinned by expanding middle‑class consumption in emerging economies and sustained premium‑product launches in mature regions. Supply is sufficiently elastic, with major producers in China, the United States, and Europe maintaining capacity expansions that keep inventories healthy. Competitive intensity is moderate to high; a handful of vertically integrated players dominate volume, while niche innovators vie for specialty segments.

The Glutamic Acid and Monosodium Glutamate market outlook remains positive, with CAGR projected above 5% through 2035 as regulatory approvals for clean‑label glutamate derivatives expand. Innovation is accelerating, focusing on enzyme‑based synthesis, reduced‑sodium formulations, and bio‑based feedstock to meet sustainability targets. However, key risk factors include volatile raw‑material prices (corn, sugar), tightening environmental regulations in China, and potential trade barriers that could disrupt the demand‑supply equilibrium. Stakeholders should monitor these variables to safeguard margins while capitalising on growth pockets.

12 items

1. Executive Summary

2. Glutamic Acid and Monosodium Glutamate Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Glutamic Acid and Monosodium Glutamate Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Glutamic Acid and Monosodium Glutamate Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Glutamic Acid and Monosodium Glutamate Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Glutamic Acid and Monosodium Glutamate Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Glutamic Acid and Monosodium Glutamate Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Glutamic Acid and Monosodium Glutamate Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Glutamic Acid and Monosodium Glutamate Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Glutamic Acid and Monosodium Glutamate Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Glutamic Acid and Monosodium Glutamate Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Glutamic Acid and Monosodium Glutamate Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Glutamic Acid and Monosodium Glutamate Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Glutamic Acid and Monosodium Glutamate Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Glutamic Acid and Monosodium Glutamate Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Glutamic Acid and Monosodium Glutamate Market Competition by Key Manufacturers

9.1. Global Glutamic Acid and Monosodium Glutamate Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Glutamic Acid and Monosodium Glutamate: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Ajinomoto

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Sunrise Nutrachem Group

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Kyowa Hakko Bio

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Royal DSM

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Prinova U.S. LLC

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Global Bio-chem Technology Group Company AnaSpec Inc.

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Tocris Bioscience Ltd

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Tokyo Chemical Industry

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Glutamic Acid and Monosodium Glutamate Market

Figure 4: Global Glutamic Acid and Monosodium Glutamate Market: Drivers

Figure 5: Global Glutamic Acid and Monosodium Glutamate Market: Challenges

Figure 6: Global Glutamic Acid and Monosodium Glutamate Market: Trends

Figure 7: Global Glutamic Acid and Monosodium Glutamate Market: Opportunity

Figure 8: Global Glutamic Acid and Monosodium Glutamate Market: Restraint

Figure 9: Global Glutamic Acid and Monosodium Glutamate Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Glutamic Acid and Monosodium Glutamate Market Value (USD Million) By Region

Figure 19: Global Glutamic Acid and Monosodium Glutamate Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Glutamic Acid and Monosodium Glutamate Market Value (USD Million) By Region

Figure 27: Global Glutamic Acid and Monosodium Glutamate Market Share (%) By: Regions (2032)

Figure 28: Global Glutamic Acid and Monosodium Glutamate Market Volume (K) By Region

Figure 29: Global Glutamic Acid and Monosodium Glutamate Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Glutamic Acid and Monosodium Glutamate Market Value (USD Million) By Region

Figure 37: Global Glutamic Acid and Monosodium Glutamate Market Share (%) By: Regions (2032)

Figure 38: Global Glutamic Acid and Monosodium Glutamate Market Volume (K) By Region

Figure 39: Global Glutamic Acid and Monosodium Glutamate Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Glutamic Acid and Monosodium Glutamate Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Glutamic Acid and Monosodium Glutamate Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Glutamic Acid and Monosodium Glutamate Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Glutamic Acid and Monosodium Glutamate Market Value (USD Million) By Region

Table 14: Global Glutamic Acid and Monosodium Glutamate Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Glutamic Acid and Monosodium Glutamate Market Volume (K) By Region

Table 31: Global Glutamic Acid and Monosodium Glutamate Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Glutamic Acid and Monosodium Glutamate Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Glutamic Acid and Monosodium Glutamate Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Glutamic Acid and Monosodium Glutamate Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Ajinomoto Basic Information And Sales Area

Table 52: Ajinomoto. Products Portfolio

Table 53: Sunrise Nutrachem Group Basic Information And Sales Area

Table 54: Sunrise Nutrachem Group. Products Portfolio

Table 55: Kyowa Hakko Bio Basic Information And Sales Area

Table 56: Kyowa Hakko Bio. Products Portfolio

Table 57: Royal DSM Basic Information And Sales Area

Table 58: Royal DSM. Products Portfolio

Table 59: Prinova U.S. LLC Basic Information And Sales Area

Table 60: Prinova U.S. LLC. Products Portfolio

Table 61: Global Bio-chem Technology Group Company AnaSpec Inc. Basic Information And Sales Area

Table 62: Global Bio-chem Technology Group Company AnaSpec Inc.. Products Portfolio

Table 63: Tocris Bioscience Ltd Basic Information And Sales Area

Table 64: Tocris Bioscience Ltd. Products Portfolio

Table 65: Tokyo Chemical Industry Basic Information And Sales Area

Table 66: Tokyo Chemical Industry. Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Type

Table 68: Global Market Share (%) By Type (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Type

Table 72: Global Market Share (%) By Type (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Glutamic Acid and Monosodium Glutamate Market Value (USD Million) By Region

Table 76: Global Glutamic Acid and Monosodium Glutamate Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Type

Table 79: North America Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Type

Table 82: Europe Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Type

Table 88: South America Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 92: Global Glutamic Acid and Monosodium Glutamate Market Volume (K) By Region

Table 93: Global Glutamic Acid and Monosodium Glutamate Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Type

Table 96: North America Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Type

Table 99: Europe Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Type

Table 105: South America Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

FAQs

1. What is the current Glutamic Acid and Monosodium Glutamate market size?

Approximately USD 1.2 billion in 2023, reflecting combined sales of food‑grade glutamic acid and MSG across food processing, seasoning, and pharmaceutical segments worldwide. The figure incorporates rapid growth from emerging economies and premium ingredient applications in recent years.

2. What is the projected growth rate and forecast through 2032?

The market is projected to expand at a compound annual growth rate (CAGR) of 5.4 % from 2024 to 2032, reaching roughly USD 1.9 billion by the end of the forecast period, driven by demand in savory‑food and nutraceutical sectors.

3. Which key drivers are fueling the Glutamic Acid and Monosodium Glutamate market?

Rising consumer preference for umami‑enhanced products, expanding processed‑food consumption in Asia‑Pacific, cost‑effective protein replacement, and increasing use of glutamic acid as a feed additive for animal nutrition collectively drive market expansion, while clean‑label trends push manufacturers toward refined, low‑sodium formulations.

4. What challenges could impede market growth?

Heightened scrutiny over sodium intake, stricter labeling regulations, price volatility of raw corn and sugar feedstocks, and occasional consumer misconceptions linking MSG to adverse health effects pose challenges that could dampen demand and increase compliance costs for producers.

5. Which regions are leading the market in 2023?

North America and Asia‑Pacific dominate, accounting for over 60 % of global sales; the United States leads in industrial applications, while China and India drive volume growth through extensive processed‑food manufacturing and expanding animal‑feed sectors.

6. Who are the top companies competing in this market?

Leading players include Ajinomoto Co., Inc., Meihua Holdings Group, CJ CheilJedang Corp., Tate & Lyle PLC, and Kyowa Hakko Bio Co., Ltd., each leveraging extensive R&D pipelines, strategic partnerships, and diversified product portfolios to capture market share.

7. What future outlook and opportunities exist for the market?

The future outlook points to growth in plant‑based protein blends, functional food ingredients, and personalized nutrition, while emerging markets present opportunities for low‑cost MSG production technologies and expanded use of glutamic acid in pharmaceutical excipients and biodegradable polymer research.

8. How is technology influencing production and applications?

Advanced fermentation, enzyme‑catalyzed synthesis, and continuous crystallization reduce energy consumption and improve purity, enabling new applications such as high‑solubility glutamate salts for sports nutrition and biodegradable packaging, thereby expanding the market’s technological frontier in global markets.

9. What regulatory trends should companies monitor?

Companies must track food safety standards such as Codex Alimentarius limits on glutamate, regional sodium‑reduction mandates, EU Novel Food approvals for new glutamic acid derivatives, and evolving labeling requirements that demand transparent MSG disclosure, all of which shape compliance strategies.

Contact for Full Report

Loading report content...

Why Is the Glutamic Acid and Monosodium Glutamate Market Growing So Fast? 2026 Analysis

Market Snapshot

Glutamic Acid and Monosodium Glutamate Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Glutamic Acid and Monosodium Glutamate Segmentation

Glutamic Acid and Monosodium Glutamate Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Glutamic Acid and Monosodium Glutamate market size?

2. What is the projected growth rate and forecast through 2032?

3. Which key drivers are fueling the Glutamic Acid and Monosodium Glutamate market?

4. What challenges could impede market growth?

5. Which regions are leading the market in 2023?

6. Who are the top companies competing in this market?

7. What future outlook and opportunities exist for the market?

8. How is technology influencing production and applications?

9. What regulatory trends should companies monitor?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Glutamic Acid and Monosodium Glutamate Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Glutamic Acid and Monosodium Glutamate Segmentation

Glutamic Acid and Monosodium Glutamate Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Glutamic Acid and Monosodium Glutamate market size?

2. What is the projected growth rate and forecast through 2032?

3. Which key drivers are fueling the Glutamic Acid and Monosodium Glutamate market?

4. What challenges could impede market growth?

5. Which regions are leading the market in 2023?

6. Who are the top companies competing in this market?

7. What future outlook and opportunities exist for the market?

8. How is technology influencing production and applications?

9. What regulatory trends should companies monitor?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation